HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noriaki Ikemoto Selected Research

Ryanodine

3/2007Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.
6/2006The RyR2 central domain peptide DPc10 lowers the threshold for spontaneous Ca2+ release in permeabilized cardiomyocytes.
3/2002Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noriaki Ikemoto Research Topics

Disease

9Heart Failure
12/2012 - 06/2005
9Malignant Hyperthermia
05/2009 - 01/2002
7Polymorphic catecholergic ventricular tachycardia
08/2011 - 09/2005
4Cardiac Arrhythmias (Arrythmia)
05/2010 - 09/2005
3Hypertrophy
09/2011 - 03/2009
3Ventricular Tachycardia
08/2011 - 06/2005
2Heart Diseases (Heart Disease)
04/2007 - 03/2002
1Inclusion Body Myositis
12/2010
1Muscular Diseases (Myopathy)
12/2010
1Sudden Death
05/2010
1Cardiomegaly (Heart Hypertrophy)
03/2009
1Myotonic Dystrophy (Dystrophia Myotonica)
03/2009
1Cardiac Sudden Death (Sudden Cardiac Arrest)
04/2008
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
09/2005
1Central Core Myopathy (Central Core Disease)
02/2002

Drug/Important Bio-Agent (IBA)

27Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
12/2012 - 01/2002
5Dantrolene (Dantrium)FDA LinkGeneric
08/2011 - 09/2002
5Peptides (Polypeptides)IBA
03/2009 - 01/2002
4Calmodulin (Calcium-Dependent Activator Protein)IBA
09/2011 - 04/2010
3RyanodineIBA
03/2007 - 03/2002
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
09/2011 - 05/2010
2Leucine (L-Leucine)FDA Link
08/2011 - 03/2009
2Proteins (Proteins, Gene)FDA Link
12/2010 - 09/2005
2Pharmaceutical PreparationsIBA
05/2009 - 09/2002
1Transcription Factors (Transcription Factor)IBA
09/2011
1Amino AcidsFDA Link
08/2011
1Serine (L-Serine)FDA Link
08/2011
1Amyloid (Amyloid Fibrils)IBA
12/2010
1EpitopesIBA
12/2010
1Endothelin-1 (Endothelin 1)IBA
05/2010
1Indicators and Reagents (Reagents)IBA
03/2009
1Carvedilol (Coreg)FDA LinkGeneric
04/2007
1Free RadicalsIBA
04/2007
1EdaravoneIBA
12/2005
1AntioxidantsIBA
12/2005
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
09/2005
1Tacrolimus Binding Proteins (FKBP)IBA
09/2005
1Acetates (Acetic Acid Esters)FDA Link
06/2005
13- ((3- cholamidopropyl)dimethylammonium)- 1- propanesulfonate (CHAPS)IBA
06/2005
1Anesthetics (Anesthetic Agents)IBA
02/2005